A simple, rapid, precise, accurate, sensitive and stability indicating high performance liquid chromatographic method has been developed for simultaneous determination of losartan potassium and hydrochlorothiazide in pharmaceutical formulations. Method development and optimization was carried out using 'Design of Experiments' (DoE). Optimized mobile phase (v/v/v) was water (containing 0.25 ml/L triethylamine), methanol and acetonitrile (60:38:30, pH adjusted to 2.7±0.1). Chromatographic separation was achieved on Hypersil®-Gold C18 (150 x 4.6 mm, 5 µm, Thermo Fisher Scientific, USA), column at 25 ± 2°C. The mobile phase flow rate was 1.0 m/min. The analysis was carried out at 271 nm using 10 µl samples. The method was validated as per the International Conference on Harmonization (ICH) guidelines. This method had a chromatographic run time of 10.0 min and a linear calibration curves ranged from 2.0 to 48.0 µg/mL for losartan potassium, and 0.5-12.0 µg/mL for hydrochlorothiazide. The limits of detection for hydrochlorothiazide and losartan potassium were 0.013 and 0.138 μg/ml while the limits of quantitations were 0.039 and 0.418 μg/ml, respectively. Stability studies indicate that the degradation of drugs was higher during oxidative stress than other stress. No photolytic degradation was observed
INTRODUCTION
Losartan potassium (LoP, Angiotensin II receptor antagonist) is chemically potassium 5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H -imidazol-1-yl] methyl} biphenyl-2-yl)tetrazol-1-ide ( Figure 1a ). Angiotensin II receptor antagonists, also known as angiotensin receptor blockers (ARBs), AT 1 -receptor antagonists or sartans, are a group of pharmaceuticals that modulate the reninangiotensin-aldosterone system. ARBs (LoP, valsartan, candisartan, irbesartan, olmisartan) are better in preventing first occurrence of atrial fibrillation than betablocker (atenolol) or calcium antagonist (amlodipine) therapy. LoP is a strong non-peptide antihypertensive agent and has a gradual, long-lasting effect as an antihypertensive. Hydrochlorothiazide (HCT), 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide is used as a diuretic (Figure 1b) . HCT is used along with different cardiovascular agent in the management of hypertension (1) (2) (3) (4) .
Recently several methods have been reported for the simultaneous determination of HCT, LoP and other drugs, including HPTLC (5) , supercritical fluid chromatography (6) , Capillary electrophoresis (7) , capillary electrochromatography (8) , spectroscopy (9) (10) (11) and HPLC (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . In biological fluids, the active principles have been determined simultaneously by LC-MS (22, 23) . These methods are not simple to perform; they are time consuming, which require careful and tedious sample -154 -preparation due to the different acid-base characteristics of the analytes, and use of expensive instruments that are usually not available in all quality control laboratories. Literature survey reveals that a non-stability indicating HPLC method (24) was developed utilizing chemometric protocol. International Conference on Harmonization (ICH) guidelines requires performance of stress tests on the drug substance, which can help to identify the likely degradation products. Moreover, validated stabilityindicating methods should be applied in the stability studies once they have demonstrated their suitability for their intended purpose (25, 26) . The aim of the present work is to develop and validate an UFLC stability-indicating method for determining HCT and LoP in its pharmaceutical dosage forms as per ICH guideline. Stress studies are performed in order to validate the stabilityindicating power of the developed analytical method and to identify the key factors that will impact the stability of the drug. Hence the present method is developed using design of experiment utilizing Box-Behnken design (27) . 
EXPERIMENTAL

Chemical and reagents
Losartan potassium (LoP) and hydrochlorothiazide (HCT) were obtained as a gift sample from Hetero Pharmaceutical Ltd, Hyderabad, India. Formulation of LoP and HCT (Losar*-H) were purchased from local pharmacies in India. Acetonitrile and methanol (HPLC grade) were purchased from Tedia Company (Fairfield, USA). Double distilled and deionised water was used throughout the analysis.
Chromatographic system and conditions
A Prominence UFLC system, consisted of a 20-AD UFLC pump, DGU-20A 3 degasser, SIL-20A autosampler, SPD-M20A photo diode array detector and a CBM-20A communication bus module (Shimadzu, Kyoto, Japan) was used. The signals were captured using LC-solution version 1.25 (2009-2010) work station (Shimadzu, Japan) operating under Microsoft Windows 7 (32 bit) platform. The pH measurements were carried out using calibrated WTW 720 pH meter equipped with a combined electrode (with ATC probe). Chromatographic separation was achieved on Hypersil ® -Gold C 18 (150 x 4.6 mm, 5 µm, Thermo-Fisher Scientific, USA) column, at 25 °C, using optimised mobile phase (v/v/v) consisting of water (containing triethylamine 0.25 ml/L), methanol and acetonitrile (60:38:30, pH 2.7 ± 0.1). The mobile phase flow rate was 1.0 ml/min. The analysis was performed at 271 nm, while the signals were captured from 200 to 350 nm using 10 µl samples.
Preparation of stock solutions, calibration standards and quality control samples
Stock solution (1 mg/ml) of LoP and HCT were prepared separately in aqueous methanol (50%) and stored in refrigerator. Working solutions, calibration standards (0.5-12 µg/ml for HCT and 2-48 µg/ml for LoP) and quality control samples (HCT-0.5, 5 and 12 µg/ml; LoP-2, 20 and 48 µg/ml) were prepared separately as required and stored in amber colored glasswares in refrigerator.
Software aided method optimization
Response surface methodology
Response surface methodology utilises "Central composite design" and "Box-Behnken design" for method development and optimization. Selection of mobile phase is an important requirement in method development. Various factors were considered for method development including, volume fraction of aqueous and organic solvents in mobile phase. In order to determine the optimal condition a Box-Behnken design (BBD) was selected as it required only 17 runs with 3 variables. In this design the extreme factors does not affect the analysis. Seventeen experiments (with three variables) were designed and constructed. The conditions, observed responses and levels described in Table 1 
Where Y is the measured response (resolution factor Rs, or retaintability T p /R t ) associated with each factor level combination: Water (A), Methanol (B) and Acetonitrile (C). The minimum and maximum volume fractions for aqueous phase were 50 and 70, respectively. The minimum and maximum volume fractions for organic phase were selected as 20 and 40, respectively.
Mobile phases of different composition (v/v/v) were prepared and the pH of the mobile phase was adjusted to 2.7 ± 0.1 (using 25% orthophosphoric acid). Samples were analysed separately and as a mixture. Retention times, ultraviolet spectrum and peak purity were used to identify different drugs. The resolution factor (R s ) and retaintability (theoretical plates T p /retention time R t ) were calculated using LC-solution chromatographic software and are presented in Table 1 . Data analysis (27) Analysis of variance (ANOVA), a regression analysis and the plotting of response surface were performed to establish optimum conditions for the separation and retaintability of analytes. ANOVA was used to test adequacy and fitness of the responses for linear, 2 function interaction (2FI) and quadratic functions of the variables. A model with P-values (P > F) less than 0.05 was regarded as significant. The lack-of-fit test was used to compare the residual and pure errors at the replicated design points. Lack of fit is measuring how well the model fits the data. Strong lack of fit (P < 0.05) is an undesirable property, because it indicates that the model doesn't fit the data well. It is desirable to have an insignificant lack of fit (P > 0.1). The highest-order significant polynomial with not significant lack of fit was selected. The predicted residual sum of the squares (PRESS) was used as a measure of fit of the model to the points in the design. After predicting the optimal conditions for separation, the experiment was repeated to ensure the reliability of the predicted values and experimental data. 
Preparation of mobile phase
The measured amount of water (600 ml, containing 0.25 ml/L TEA), methanol (380 ml each) and acetonitrile (300 ml) were transferred in HPLC bottle separately. The final pH was adjusted to 2.7 ± 0.1, using 25% orthophosphoric acid. Mobile phase was filtered through 0.22 m nylon filters and degassed using ultrasonic bath (Branson, Model 3210, USA).
Preparation of Sample for Assay
Average weight of twenty tablets (containing 12.5 mg HCT and 50 mg LoP) was determined. Tablets were triturated to a fine powder. A quantity of powder equivalent to 12.5 mg HCT and 50 mg LoP was weighed accurately and transferred to 100 ml calibrated volumetric flask. Aqueous methanol (50%, 25mL) was added and contents were sonicated for 10 minutes. The volume was made up to the mark. The solution was filtered through 0.45 µm nylon filter (Micro-syringe filter). Appropriate dilutions (in the calibration range) were prepared for analysis.
Analytical Method validation
The analytical method was validated for accuracy, precision, limit of detection (LOD), limit of quantitation (LOQ), specificity, robustness and ruggedness as per recommendation of International Conference on Harmonisation (International Conference on Harmonisation, 2005).
Linearity, LOD, and LOQ
Calibration standards (HCT 0.5-12 µg/ml and LoP 2-48 µg/ml) were prepared using aliquots of stock solution (1000 µg/ml) or working solutions (50, 100, 500 µg/ml) of HCT and LoP. Replicates of each concentration were independently prepared and injected into the chromatograph. Linearity was evaluated by the linear least-squares regression model. Microsoft office excel 2007 was used for statistical analysis. The method was validated according to ICH guidelines. A 5% significance level was used for evaluation. LOD and LOQ were calculated as 3.3×σ n-1 /S and 10×σ n-1 /S, where σ n-1 is the standard deviation of the intercept and S is the slope of the calibration curve. 
System Suitability
System suitability was evaluated using data analysis of six replicate injections of a sample solutions (8.0 µg/ml HCT and 32.0µg/ml LoP) according to "USP" (28) .
Chromatographic parameters like retention time, area (AUC), peak height (AU), tailing factor, theoretical plate, USP width and height equivalent to theoretical plates (HETP) were studied and the precision (RSD) was evaluated. The precision, as measured by coefficient of variation was determined at each set parameters and it should be less than 2%.
Precision
Quality control samples (n=3) were analysed on different occasions (n=3) and three different days. The precision (RSD) of the method was determined as intraday precision (repeatability) and intermediate precision. The intermediate precision was estimated from the RSD of the analysis of the samples prepared at the same concentration but on 3 different days at different concentration levels, while intraday precision was calculated by analyzing the same concentration during the same day at different time. 
Ruggedness
Ruggedness was accessed by intentionally changing the chromatographic parameters (wavelength or flow rate) and evaluating their impact on analysis. The ruggedness of the method was evaluated on the basis of precision (RSD < 2%).
Stability Studies
Stress studies like oxidative, alkaline, acidic stress, exposure to sunlight and UV light (254 nm), were conducted using raw material and tablets. Samples were exposed to different stressed conditions, processed and analyzed (n=3). The chromatograms of the samples were compared with those of control samples that were freshly prepared from the stock solution and without stress. All samples were analyzed in triplicate. The peak purity was checked using the chromatographic tools of the LCSolution software. This assessment was based on the comparison of spectra recorded during the elution of the peak. UV spectra and peak purity were used to assess purity of analyte. For evaluation of oxidative stress, HCT (5 mg) and LoP (20 mg) were weighed accurately and transferred to 50 ml volumetric flask. Five ml hydrogen peroxide (25%) was added, and content were shaken for an hour. The contents were diluted to 50 ml with mobile phasE. Similarly for evaluation of acidic or alkaline stress, analytes (HCT 5 mg and LoP 20 mg) were weighed accurately and transferred to 50 ml volumetric flask. These samples were shaken with 5 ml of either 1M hydrochloric acid (HCl) or 1M sodium hydroxide (NaOH) for 1 h. After one hour the content were diluted to 50 ml with mobile phase.
A physical mixture of HCT and LoP (1g, 20:80, w/w) was placed in an open watch glass and exposed to either UV-irradiation (~100 W/m 2 ) or direct sunlight for two hours with occasionally shifting of the content using stainless steel spatula. After 2 hours, 25 mg of sample was weighed, transferred to 50 ml volumetric flask and dissolved in mobile phase. All the solutions were suitably diluted and analyzed. Stress studies were also conducted on tablet formulation. Tablet triturate (powder) equivalent to 5mg of HCT and 20 mg of LoP was used in stress testing. Samples were processed and analyzed as described above.
RESULTS AND DISCUSSION
Analytical Method Development
In order to achieve optimum separation various parameters like solvent, solvent strength, detection wavelength, flow rate, elution time, asymmetry, and theoretical plate numbers were considered. During method development the column was saturated for atleast 1 hour with different mobile phases prior to analysis. Analytes were analysed using 17 different mobile phases (as per Box-Behnken Design protocol) and the retention time, tailing factor, retaintability along with resolution factor was calculated. HCT and LoP were eluted at ~2.0 and 5.4 min using optimised mobile phase. Although temperature was found not to be a critical parameter for this analysis, it was set at 25 ± 2°C. The absorption maximum of the drug at 271 nm was selected for detection, as there was no interference from excipients present in drug. The resolution factor was ~10.75. 
Design of experiment and method optimization
A three factorial, Box-Behnken design was performed using 17 experimental runs. The independent, dependent variables and observed responses for all 17 trial experiments are given in Table 1 -2. It was observed that the best fitted model was the quadratic model for different responses. The comparative values of R and SD for different proposed models are given in Table 3 , along with regression equation generated for the finally selected response. Only statistically significant (p < 0.05) coefficient are included in the regressed equation after model reduction (insignificant model terms are removed to improve the model). A positive value in the equation indicates the favourable response while a negative value indicates an inverse relationship between the factor and the response. It is clear from the equations that the factor buffer (A) has a positive effect on the resolution factor, while acetonitrile (B) and methanol (C) are having negative effect. In case of retaintability these factors are producing opposite effect (Table 3) .
Two dimensional contour plot and 3D response surface plots are presented as Fig. 3 (a-f) , which are very useful for studying the interaction effects of independent factors on the responses. The coefficients for the model were estimated by least squares regression. The relationship between the response factors (R s and retaintability) and independent factors is quadratic. An independent factor can produce different degree of response when the different factors (A, B or C) are changed simultaneously. Interaction of B and C, as well as A and C produce positive impact on resolution factor or retaintability). The square of factor A 2 is having negative impact on resolution of HCT and LoP; while B 2 and C 2 are having negative impact on retaintability factor (T p /R t ) ( Table 3) . As observed, an increase in buffer concentration at constant methanol and acetonitrile content increases the resolution factor (R s ). It is evident from the steepness of the curve that at constant buffer and methanol content, acetonitrile has significant influence on the resolution factor R s (Fig. 3a, b) . Keeping these observations in knowledge the resolution factor R s was considered during method optimization and mobile phase selection step. It is evident from Fig. 3c-f , that the interaction of methanol (B) and acetonitrile (C), BC is having positive impact on retaintability. An increase in buffer content at constant methanol (B=30) and acetonitrile (C=30) content decreases the retaintability of HCT and LoP.
The final composition of the mobile phase for simultaneous determination of these compounds was selected using Design Expert ® software (Version 8.0.6, Stat-Ease, USA) after studying the 2D contour and 3D response surface plots. Resolution factor R s was kept constant to 11.0 during the optimization step. The desirability plot (Fig. 3g) and several different mobile phase compositions were generated by the software. Using desirability plot, the optimized mobile phase (having desirability factor 1.000) was selected for analysis. Different drug combinations were analysed and the resolution factor was calculated. The observed resolution factor (R s ) was 10.75, using optimized chromatographic conditions. The results indicate that the present method is capable of separating HCT and LoP with significant retaintability. The developed and optimized mobile phase exhibit good resolution and reproducible results. The present method is rapid and stability indicating as compared to the method developed using chemometric protocol (24) . The typical chromatogram obtained during the analysis are given in Fig. 2a-b . 
Method Validation
The method was validated in respect to parameters like linearity, limit of quantitation (LOQ), limit of detection (LOD), precision, accuracy, specificity, robustness, system suitability and stability.
Linearity, LOD and LOQ
Calibration curves (n=5) were linear over the concentration range of 0.5-12 µg/ml and 2-48 µg/ml for HCT and LoP respectively. respectively (r 2 ≥ 0.9999), using weighting factor-x (Table 4) . The LOD and LOQ for HCT were 0.013 and 0.039 µg/ml, respectively. While for LOP 0.138 and 0.418 µg/ml respectively.
Accuracy and Precision
The accuracy and precision of the analytical method were established across its linear range as indicated in the guideline. Table 5 reveals that excellent recoveries were made at different concentration levels (80%, 100% and 120%) using present method. The percent recoveries were ranged from 99.6-100.9% and 99.9-100.8% for LoP and HCT respectively ( Table 5 ). The intra-day precision and inter-day precision were less than 1.45 % and 1.78 % respectively (Table 6 ). Low precision values indicate the repeatability of the developed analytical method.
Specificity
Specificity of the method was assessed by comparing the chromatograms obtained from raw material and extracted drugs from formulation. The retention times of drug from standard solutions and formulation were identical and no co-eluting peaks or impurity from the diluents were observed, indicating specific method for quantitative estimation of drug in the commercial formulation (Figure 2 and inset) 
System Suitability
System suitability parameters were studied with six replicates standard solution of the drugs and the calculated parameters are within the acceptance criteria.
The tailing factor, the number of theoretical plates and HETP were in the acceptable limits (RSD less than 2%). The system suitability results are shown in Table 7 .
Robustness
Robustness of the methods was illustrated by getting the resolution factor and tailing factor, when mobile phase flow rate (± 0.1 ml/min) and wave-length (± 2 nm) were deliberately varied. The deliberate changes in the method do not affect the resolution and tailing factor of analytes significantly (data on file).
Stability
The prepared stock and working solutions were stable for 15 days when stored in refrigerator (2-8˚C). No degraded products were observed during studies. The peak purity was 0.999 or more during the validation studies. On exposure to hydrogen peroxide (25%), HCT and LoP produces several minor degradation products having retention time 2.76, 2.97, 3.42, 3.59, 4.02, 4.18, 5.88, 9.58 and 10.32 min. The percent LoP and HCT remained were 60.85 and 96.72% respectively. In case of alkaline stress, the degradation products were observed at 3.19, 3.98 and 7.99 min. On exposure to the acidic stress analytes gave two minor products (6.83 and 10.72 min) (Table 8) . On exposure to different stress conditions, the degradation of LoP and HCT in was lesser than API, which might be due to presence of pharmaceutical excipients. One minor oxidative product was noticed during the studies. The analytes were well separated from the degraded compounds. Figure 4 illustrate the chromatograms obtained during the stability studies. 
Assay
The proposed method was applied for the assay of Tablet formulations of HCT and LoP. The assay of HCT and LoP were 99.4 and 99.1% respectively. The percent purity of HCT and LoP were 99.5 and 99.6% respectively, in case of API. There were no significant difference between the assays obtained using the present method and the reported method (24) . Low value of precision indicates that the method can be used precisely for the estimation of drug in formulations ( Table 9 ). The present results indicate that the validated method is having advantages over the other methods which are summarised in Table 10 . This isocratic method is more sensitive than the stability indicating method reported by Hertzog et al. (2002) (12) and other methods ( 6, (10) (11) 14, 17, (20) (21) 24) .The regression and validation parameters are summarised in Table 11 . CONCLUSION A new HPLC method for the estimation of hydrochlorothiazide and losartan potassium has been developed using design of experiments using Box-Behnken design and validated as per ICH guideline. The present method is simple, rapid, economical, accurate, precise, specific, robust and stability indicating. As the method is developed and optimised using DoE and software program, it can be further optimized as required. The short run time enables the rapid separation of analytes for routine analysis of formulations. No interference has been observed from the excipients or degraded product. 
